Theorem Clinical Research

Global News

Science for Life Laboratory forms Swedish National Center

Monday, February 9, 2015 12:09 PM

Science for Life Laboratory (SciLifeLab) has established the Swedish National Center for Single-Cell Biology. The center features six C1TM systems, three CyTOF 2 systems and a Biomark HD system, making SciLifeLab one of the preeminent users of the full line of Fluidigm’s single-cell technologies in the world. Fluidigm develops, manufactures and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. Fluidigm products are provided for research use only.

More... »

Quest Diagnostics

Exact Sciences, Mayo Clinic extend, expand collaboration

Monday, February 9, 2015 12:06 PM

Exact Sciences, a Madison, Wis.-based molecular diagnostics company, and Rochester, Minn.-based Mayo Clinic have announced a five-year extension and expansion of their collaboration, broadening their efforts to develop screening, surveillance and diagnostic tests beyond colorectal cancer to address other diseases within the gastrointestinal tract.

More... »


Making Patient Engagement part of Site Routine

Monday, February 9, 2015 07:00 AM

There is a new trend afoot in “patient engagement,” related not only to clinical trials, but also to healthcare today.

More... »

Roche, Qualcomm collaborate to innovate remote patient monitoring

Friday, February 6, 2015 12:29 PM

Qualcomm's subsidiary, Qualcomm Life, and Roche, a Swiss-based provider of point-of-care diagnostics, have entered into a strategic collaboration to improve remote monitoring and management of chronic disease patients.

More... »

Certara promotes Amin Rostami to senior vice president of R&D, chief scientific officer

Thursday, February 5, 2015 01:41 PM

Certara, a global biosimulation technology-enabled drug development and drug safety consulting company, has promoted Amin Rostami, Pharm.D., Ph.D., to senior vice president of R&D and chief scientific officer at Certara. Professor Rostami previously was co-founder and vice president of R&D for Certara’s Simcyp Business Unit.

More... »

Cord Blood Registry forms scientific and medical advisory board

Thursday, February 5, 2015 01:17 PM

Cord Blood Registry (CBR) has announced the establishment of a scientific and medical advisory board (SMAB). Composed of internationally renowned stem cell experts, the SMAB will provide input and guidance to help advance CBR's mission to expand the scope of newborn stem cell therapies that may be available to patients and their families. The founding members of the SMAB are Dr. Charles Cox, Dr. Mahendra Rao, Dr. Leslie Silberstein and Dr. Alan Trounson. Rao will be the inaugural chairman of the SMAB, and he also will be acting as CBR's chief clinical and regulatory advisor.

More... »

Ebola vaccine trial opens in Liberia

Thursday, February 5, 2015 01:09 PM

A large clinical trial to assess the safety and efficacy of two experimental vaccines to prevent Ebola virus infection now is open to volunteers in Liberia. The trial is being led by a recently formed Liberia-U.S. clinical research partnership and is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The Partnership for Research on Ebola Vaccines in Liberia or PREVAIL, a phase II/III study, is designed to enroll approximately 27,000 healthy men and women aged 18 years and older.

More... »

Lycera names Paul Sekhri president and CEO

Thursday, February 5, 2015 12:58 PM

Lycera, a biopharmaceutical company developing breakthrough medicines to treat cancer and autoimmune disease, has named Paul Sekhri president, CEO and a member of the board of directors, effective immediately. Sekhri brings more than 25 years of operational experience in the life sciences industry, including business development and strategy, general management, drug development, and commercial strategy.  He succeeds Kathleen M. Metters, Ph.D., who currently serves as senior advisor to the company.

More... »

NIHR, Janssen partner on rheumatoid arthritis biological treatments

Thursday, February 5, 2015 12:50 PM

A new clinical research study has been launched that will explore why the current gold standard biological treatment for people with rheumatoid arthritis does not work in around a third of patients. The National Institute for Health Research (NIHR) study in partnership with Janssen will investigate key mechanisms associated with a lack of response to this treatment and its findings should open new routes for developing therapies for these patients.

More... »

Neomed creates a new Biologics and Vaccine Center of Excellence

Thursday, February 5, 2015 12:15 PM

Neomed has launched the Biologics and Vaccine Center of Excellence in Laval under a proposed partnership with GlaxoSmithKline (GSK). This Center will be unique in Canada and GSK has committed $47 million towards its establishment. Neomed is a nonprofit that fosters the development of promising therapeutic approaches emerging from academia and biotechnology companies and is jointly funded by the pharmaceutical industry, the Ministère de l'Économie, de l'Innovation et des Exportations du Québec and the Networks of Centers of Excellence (NCE) of Canada.

More... »

`

CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs